A Deforest
Overview
Explore the profile of A Deforest including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pelletier L, Duclos P, Gill P, Deforest A
Can J Infect Dis
. 2012 Feb;
9(6):367-71.
PMID: 22346556
Objective: To assess immunity to diphtheria in a sample of Canadian adults. Design: A seroprevalence study of a group of plasmapheresis donors was performed over a four-month period in 1996....
2.
Dudas R, Hoshino Y, Nehring P, SPERBER E, Wagner M, Stephens I, et al.
Vaccine
. 2001 Sep;
19(32):4676-84.
PMID: 11535316
The safety and immunogenicity of an orally administered, live rotavirus vaccine comprised of four strains, each with a titer of 10(5.3) or 10(5.8) pfu, and each having 10 genes from...
3.
Khetsuriani N, Music S, Deforest A, Sutter R
J Infect Dis
. 2000 Feb;
181 Suppl 1:S208-12.
PMID: 10657216
To determine the immunogenicity and safety of a single dose of diphtheria toxoid among adults, blood samples for detecting serum antitoxin levels were obtained from 18- to 59-year-old subjects (n=248)...
4.
Golaz A, HARDY I, Glushkevich T, Areytchiuk E, Deforest A, Strebel P, et al.
J Infect Dis
. 2000 Feb;
181 Suppl 1:S203-7.
PMID: 10657215
Epidemic diphtheria spread to Ukraine in 1991, where it peaked in 1995 with >5,000 reported cases. To refine epidemic control strategies, immunogenicity of a tetanus-diphtheria toxoids vaccine (Td) containing 2...
5.
Sutter R, HARDY I, Kozlova I, Tchoudnaia L, Gluskevich T, Marievsky V, et al.
J Infect Dis
. 2000 Feb;
181 Suppl 1:S197-202.
PMID: 10657214
After 30 years of control, epidemic diphtheria returned to the Soviet Union in 1990. To develop control strategies, the immunogenicity of the tetanus and diphtheria toxoids (Td) vaccine was assessed....
6.
Auerbach B, Lake A, Wilson M, Willingham F, Shematek J, Moulton L, et al.
Biologicals
. 1998 Nov;
26(2):145-53.
PMID: 9811522
In an effort to determine the optimal dose of pertussis toxoid (PT) and filamentous haemagglutinin (FHA) for use in acellular pertussis vaccines we compared the immunogenicity and safety of acellular...
7.
Quien R, Kaiser B, Deforest A, Polinsky M, Fisher M, Baluarte H
J Pediatr
. 1997 Dec;
131(5):688-90.
PMID: 9403647
Varicella vaccine was administered to seven children with corticosteroid-sensitive nephrotic syndrome. Immunization was not associated with any significant reactions or with increased frequency of relapse. The antibody response was, however,...
8.
Pichichero M, Deloria M, Rennels M, Anderson E, Edwards K, Decker M, et al.
Pediatrics
. 1997 Nov;
100(5):772-88.
PMID: 9346976
Objective: To compare the safety and immunogenicity of 12 different acellular pertussis vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria, tetanus, and whole-cell pertussis vaccine (DTwP)...
9.
Flynn J, Kaiser B, Long S, Schulman S, Deforest A, Polinsky M, et al.
Am J Nephrol
. 1997 Jan;
17(2):146-52.
PMID: 9096445
Cytomegalovirus (CMV), the most significant infectious cause of morbidity following renal transplantation, may be a greater problem for children than for adults due to their relative lack of experience with...
10.
Edvardsson V, Flynn J, Deforest A, Kaiser B, Schulman S, Bradley A, et al.
Clin Transplant
. 1996 Dec;
10(6 Pt 1):556-60.
PMID: 8996778
Viral infections such as influenza are an important cause of morbidity following organ transplantation. We evaluated the immunogenicity of a commercially available influenza vaccine in pediatric renal transplant recipients in...